Manx Financial Group PLC Issue of Shares pursuant to Scrip Dividend & TVR (7069F)

TIDMMFX

RNS Number : 7069F

Manx Financial Group PLC

12 July 2023

   FOR IMMEDIATE RELEASE                                                  12 July 2023 

Manx Financial Group PLC (the "Group")

Issue of Ordinary Shares pursuant to the Scrip Dividend

and Total Voting Rights

Further to the announcement made on 30(th) May 2023 in relation to the Scrip Dividend, the Group announces that it has received valid elections from shareholders resulting in a requirement to issue 418,993 New Ordinary Shares ("New Shares") at a price of 21.8974 pence per share.

Jim Mellon and Dr Gregory Bailey, both Directors and significant shareholders of the Group, have elected to be issued 78,900 and 65,384 Ordinary Shares of no par value ("Ordinary Shares") respectively at a price of 21.8974 pence per share representing their partial Script Dividend entitlements, thus maintaining their joint percentage holding under the Concert Party whitewash waiver approved on 9(th) April 2020. Douglas Grant and Alan Clarke, also Directors of the Group, have elected to receive Ordinary Shares under the Scrip Dividend as further set out in the table below.

Application has been made for the total of 418,993 New Shares to satisfy the Scrip Dividend exercise, which will rank pari passu with all existing Ordinary Shares, to be admitted to trading on AIM. Admission is expected on or around 19(th) July 2023.

Following the issue of the New Shares and Additional Allotment, the Company's issued share capital consists of 115,491,981 Ordinary Shares of no-par value, with voting rights ("Ordinary Shares"). The Company does not hold any Ordinary Shares in Treasury. Therefore, the total number of Ordinary Shares in the Company with voting rights is 115,491,981 .

Directors' Dealings

The respective holdings of the Directors following the issue of ordinary shares pursuant to the Scrip Dividend:

 
                       Scrip Shares Issued   Total number of shares held   % of Issued Capital 
 Jim Mellon (1)                     78,900                    21,748,214                 18.83 
 Gregory Bailey (2)                 65,384                    18,022,674                 15.61 
 Douglas Grant                       9,178                       543,129                  0.47 
 Alan Clarke                           946                        55,994                  0.05 
 

(1) Burnbrae Limited holds 19,420,232 Ordinary Shares. Burnbrae Limited is 100% beneficially owned by Jim Mellon. Denham Eke, Executive Vice-Chairman of MFG, is also a director of Burnbrae Limited. Vidacos Nominees Limited also holds 2,327,982 Ordinary Shares in trust for Jim Mellon.

   (2)      Vidacos Nominees Limited holds 18,022,674 Ordinary Shares in trust for Gregory Bailey. 

Total Voting Rights

The figure of 115,491,981 Ordinary Shares may be used by shareholders in the Group from the date of admission as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the shares of the Group under the Financial Conduct Authority's Disclosure and Transparency Rules.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET ABUSE REGULATION (EU No. 596/2014) AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN AND SUCH PERSONS SHALL THEREFORE CEASE TO BE IN POSSESSION OF INSIDE INFORMATION.

For further information, please contact:

 
 Manx Financial Group       Beaumont Cornish Limited              Greentarget Limited 
  PLC                        Roland Cornish/James                  Jamie Brownlee 
  Denham Eke,                Biddle                                Tel: [phone] 
  Executive Vice Chairman    Tel [phone]                   5726 
  Tel [phone]     3396 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCGPUAAMUPWGQG

(END) Dow Jones Newswires

July 12, 2023 02:00 ET (06:00 GMT)